![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Chsy3 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHSY3 mRNA | CTD | PMID:36331819 | Chsy3 | Mouse | 17beta-estradiol | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of CHSY3 mRNA | CTD | PMID:20660070 | Chsy3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CHSY3 mRNA | CTD | PMID:19770486 | Chsy3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHSY3 mRNA | CTD | PMID:32109520 | Chsy3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CHSY3 mRNA | CTD | PMID:26290441 | Chsy3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CHSY3 mRNA | CTD | PMID:22298810 | Chsy3 | Mouse | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | Chsy3 | Mouse | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of CHSY3 mRNA | CTD | PMID:30951980 | Chsy3 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | ISO | CHSY3 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of CHSY3 gene | CTD | PMID:31601247 | Chsy3 | Mouse | aristolochic acid A | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CHSY3 mRNA | CTD | PMID:33212167 | Chsy3 | Mouse | benzo[a]pyrene | increases mutagenesis | ISO | CHSY3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of CHSY3 gene | CTD | PMID:25435355 | Chsy3 | Mouse | benzo[a]pyrene | affects methylation | ISO | CHSY3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CHSY3 promoter | CTD | PMID:27901495 | Chsy3 | Mouse | benzo[a]pyrene | increases methylation | ISO | CHSY3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CHSY3 exon | CTD | PMID:27901495 | Chsy3 | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CHSY3 mRNA | CTD | PMID:19770486 | Chsy3 | Mouse | bisphenol A | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CHSY3 mRNA | CTD | PMID:25181051 | Chsy3 | Mouse | bisphenol A | decreases methylation | ISO | CHSY3 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CHSY3 gene | CTD | PMID:31601247 | Chsy3 | Mouse | bisphenol A | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CHSY3 mRNA and bisphenol A results in decreased expression of CHSY3 protein | CTD | PMID:29275510 and PMID:33376534 | Chsy3 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CHSY3 mRNA | CTD | PMID:30951980 and PMID:34585602 | Chsy3 | Mouse | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of CHSY3 mRNA | CTD | PMID:38685157 | Chsy3 | Mouse | butanal | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of CHSY3 mRNA | CTD | PMID:26079696 | Chsy3 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Chsy3 | Mouse | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of CHSY3 mRNA | CTD | PMID:37019170 | Chsy3 | Mouse | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHSY3 gene | CTD | PMID:20938992 | Chsy3 | Mouse | cisplatin | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Cisplatin results in decreased expression of CHSY3 mRNA | CTD | PMID:22023808 | Chsy3 | Mouse | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHSY3 mRNA | CTD | PMID:30529165 | Chsy3 | Mouse | dorsomorphin | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHSY3 mRNA | CTD | PMID:27188386 | Chsy3 | Mouse | doxorubicin | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CHSY3 mRNA | CTD | PMID:29803840 | Chsy3 | Mouse | endosulfan | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of CHSY3 mRNA | CTD | PMID:29391264 | Chsy3 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHSY3 gene | CTD | PMID:20938992 | Chsy3 | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CHSY3 gene | CTD | PMID:20938992 | Chsy3 | Mouse | lipopolysaccharide | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CHSY3 mRNA | CTD | PMID:35811015 | Chsy3 | Mouse | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CHSY3 mRNA | CTD | PMID:24535843 | Chsy3 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CHSY3 mRNA | CTD | PMID:17562736 | Chsy3 | Mouse | paracetamol | increases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of CHSY3 mRNA | CTD | PMID:33387578 | Chsy3 | Mouse | paracetamol | increases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CHSY3 mRNA | CTD | PMID:29067470 | Chsy3 | Mouse | paracetamol | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CHSY3 mRNA | CTD | PMID:26690555 | Chsy3 | Mouse | paraquat | decreases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of CHSY3 mRNA | CTD | PMID:32680482 | Chsy3 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHSY3 mRNA | CTD | PMID:36331819 | Chsy3 | Mouse | progesterone | increases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Progesterone results in increased expression of CHSY3 mRNA | CTD | PMID:20864642 | Chsy3 | Mouse | progesterone | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of CHSY3 mRNA | CTD | PMID:20660070 | Chsy3 | Mouse | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CHSY3 mRNA | CTD | PMID:35811015 | Chsy3 | Mouse | SB 431542 | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHSY3 mRNA | CTD | PMID:27188386 | Chsy3 | Mouse | sodium arsenite | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CHSY3 mRNA | CTD | PMID:25879800 | Chsy3 | Mouse | sunitinib | decreases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CHSY3 mRNA | CTD | PMID:31533062 | Chsy3 | Mouse | temozolomide | increases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of CHSY3 mRNA | CTD | PMID:31758290 | Chsy3 | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CHSY3 mRNA | CTD | PMID:31919559 | Chsy3 | Mouse | thioacetamide | increases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CHSY3 mRNA | CTD | PMID:34492290 | Chsy3 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of CHSY3 gene and titanium dioxide results in decreased methylation of CHSY3 promoter | CTD | PMID:35295148 | Chsy3 | Mouse | trichloroethene | increases expression | ISO | Chsy3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CHSY3 mRNA | CTD | PMID:33387578 | Chsy3 | Mouse | trichostatin A | increases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CHSY3 mRNA | CTD | PMID:24935251 | Chsy3 | Mouse | valproic acid | affects expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CHSY3 mRNA | CTD | PMID:25979313 | Chsy3 | Mouse | valproic acid | increases methylation | ISO | CHSY3 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CHSY3 gene | CTD | PMID:29154799 | Chsy3 | Mouse | valproic acid | increases expression | ISO | CHSY3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CHSY3 mRNA | CTD | PMID:23179753 more ... | Chsy3 | Mouse | valproic acid | multiple interactions | ISO | CHSY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHSY3 mRNA | CTD | PMID:27188386 | |